Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

Coxiron 90mg tablets

Ferron Par Pharmaceuticals

Ingredients in every tablet

Etoricoxib 90 mg

Each package contains

3 blisters of 10 tablets

Dosage form

tablet

Dosage formTablet; coated

Flavour

None

W.H.O. classification

M01A
M01A

A.T.C. Level 1

Anatomical Main group

M - Musculo-skeletal system
M01A

A.T.C. Level 2

Therapeutic subgroup

M01 - Antiinflammatory and Antirheumatic Products
M01A

A.T.C. Level 3

Pharmacological subgroup

M01A - Antiinflammatory and Antirheumatic Products; Non-Steroids

Available in

Indonesia

Warnings

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CONSULT YOUR DOCTORSafety of this item for use while operating heavy machinery has not been established. Please consult your doctor.

Pregnancy

NOT RECOMMENDEDThis item is not safe for use during pregnancy.

Lactation

NOT RECOMMENDEDThis item is not safe for use during lactation.

Indication

Etoricoxib is indicated for:
Osteoarthritis (OA)
Symptom relief in the treatment of osteoarthritis (OA) (I p.1, II p.54, III p.1, IV p.1)
Chronic musculoskeletal pain
Relief of chronic musculoskeletal pain (I, III p.1)
Dental surgery
Relief of acute pain associated with dental surgery (I, III p.1, IV p.1)

Dosage

18 YEARS OLD AND ABOVE
Etoricoxib is given orally with or without food.

Arthritis (Osteoarthritis):
The recommended dose is 60 mg once daily.

Analgesia:
Acute pain associated with dental surgery:
The recommended dose is 120 mg once daily. Etoricoxib 120 mg should be used only for the acute symptomatic period.

Chronic musculoskeletal pain:
The recommended dose is 60 mg once daily

Doses greater than those recommended for each indication have either not demonstrated additional efficacy or have not been studied. Therefore, the dose for each indication is the maximum recommended dose.

Etoricoxib is administered orally. Etoricoxib may be taken with or without food.

ELDERLY PATIENTS
No dosage adjustment in etoricoxib is necessary for the elderly.

GENDER AND RACE
No dosage adjustment in etoricoxib is necessary based on gender or race.

PATIENTS WITH HEPATIC INSUFFICIENCY
— Mild hepatic insufficiency (Child-Pugh score 5-6):
A dose of 60 mg once daily should not be exceeded

— Moderate hepatic insufficiency (Child-Pugh score 7-9):
The dose should be reduced; a dose of 60 mg every other day should not be exceeded, administration of 30 mg once daily can also be considered.

— Severe hepatic insufficiency:
There are no clinical or pharmacokinetic data in patients with severe hepatic insufficiency (Child-Pugh score >9)

PATIENTS WITH RENAL INSUFFICIENCY
In patients with advanced renal disease (creatinine clearance <30 ml/min), treatment with etoricoxib is not recommended. No dosage adjustment is necessary for patients with lesser degrees of renal insufficiency (creatinine clearance ≥30 ml/min)